Genomics 10x Guides Q4 and Fiscal Year Higher Than Consensus (TXG:NASDAQ)


3rd to 4th quarter symbol. Wooden cubes turned and words changed

Dmitri Dzemidovich

  • 10x Genomics (NASDAQ:TXG) wait Q4 revenue of ~$165M, representing 9% Q/Q growth and 10% YoY decline; the number remains above the consensus estimates of 153.51 million dollars.
  • The highest year-on-year growth is estimated to come from the services segment, while instruments



Source link

  • Related Posts

    Zuckerberg says most companies need more ‘masculine energy’

    Zuckerberg, who launched his career by rating the attractiveness of women at Harvard University, lamented the rise of “culturally neutered” companies. Read More Source link

    The inauguration is coming, and Trump Media stock is rising

    Scott Olson/Getty Images The Trumpiest part of the “Trump Trade” is back on today. In this case, we’re referring to “Trumpiest” because it’s in the stock of the company named…

    Leave a Reply

    Your email address will not be published. Required fields are marked *